Hypercoagulability in the Nephrotic syndrome.

作者: K. Andrassy , E. Ritz , J. Bommer

DOI: 10.1007/BF01476873

关键词: PlateletBeta-thromboglobulinInternal medicineAntithrombinEndocrinologyImmunologyFibrinolysisChemistryFibrinogenPlatelet factor 4CoagulationNephrotic syndrome

摘要: The risk of thromboembolic complications in patients with the nephrotic syndrome (NS) is higher than any other condition encountered internal medicine. Such comprise venous thromboses (calf, thigh, renal vein) or without pulmonary embolism and arterial (coronary thromboses, cerebral artery peripheral thromboses). Several defects plasmatic coagulation system, fibrinolysis platelet function had been recognized syndrome. Increased hepatic synthesis causes a rise factors, I, II, VII, VIII, X increased loss lowering plasma concentration antithrombin III concentration. There little evidence for DIC. Plasminogen diminished, whereas total antiplasmin activity increased. Low alpha-1-antitrypsin secondary to outweighed by concentrations inhibitors especially alpha-2-macroglobulin alpha-2-antiplasmin. common presence material urine reacting as fibrin degradation products passive hemagglutination techniques appears be proteolytically degraded fibrinogen excreted result non-selective glomerular proteinuria. Platelet counts are normal slightly elevated survival time slightly, decreased. Definite abnormalities spontaneous aggregation ADP- collagen-induced demonstrable. Furthermore, arachidonic acid induced malondialdehyde formation platelets NS Addition albumin normalises aggregation. This finding points some acquired defect function.

参考文章(35)
A K Sinha, S J Shattil, R W Colman, Cyclic AMP metabolism in cholesterol-rich platelets. Journal of Biological Chemistry. ,vol. 252, pp. 3310- 3314 ,(1977) , 10.1016/S0021-9258(17)40389-9
R.Charles Curry, William C. Roberts, Status of the coronary arteries in the nephrotic syndrome The American Journal of Medicine. ,vol. 63, pp. 183- 192 ,(1977) , 10.1016/0002-9343(77)90231-5
Ewa Marciniak, Claude H. Farley, Philip A. DeSimone, Familial Thrombosis Due to Antithrombin III Deficiency Blood. ,vol. 43, pp. 219- 231 ,(1974) , 10.1182/BLOOD.V43.2.219.219
John L. Duffy, Joseph Letteri, Thomas Cinque, Peck Pohsiung Hsu, Laura Molho, Jacob Churg, Renal vein thrombosis and the nephrotic syndrome The American Journal of Medicine. ,vol. 54, pp. 663- 672 ,(1973) , 10.1016/0002-9343(73)90125-3
D.A. Handley, J.R. Lawrence, FACTOR-IX DEFICIENCY IN THE NEPHROTIC SYNDROME The Lancet. ,vol. 289, pp. 1079- 1081 ,(1967) , 10.1016/S0140-6736(67)92651-7
PHILLIP A. TREW, CLAUDE G. BIAVA, RICHARD P. JACOBS, JAMES HOPPER, Renal vein thrombosis in membranous glomerulonephropathy: incidence and association. Medicine. ,vol. 57, pp. 69- 82 ,(1978) , 10.1097/00005792-197801000-00005
Victor E. Pollak, Robert M. Kark, Conrad L. Pirani, Harold A. Shafter, Robert C. Muehrcke, Renal vein thrombosis and the nephrotic syndrome The American Journal of Medicine. ,vol. 21, pp. 496- 520 ,(1956) , 10.1016/0002-9343(56)90067-5
C L Hall, N Pejhan, J M Terry, J D Blainey, Urinary fibrin-fibrinogen degradation products in nephrotic syndrome. BMJ. ,vol. 1, pp. 419- 422 ,(1975) , 10.1136/BMJ.1.5955.419
K. Andrassy, E. Ritz, Biochemie und klinische Bedeutung von Urokinase Deutsche Medizinische Wochenschrift. ,vol. 103, pp. 1015- 1020 ,(1978) , 10.1055/S-0028-1104824
George R. Honig, Annabelle Lindley, Deficiency of Hageman factor (factor XII) in patients with the nephrotic syndrome The Journal of Pediatrics. ,vol. 78, pp. 633- 637 ,(1971) , 10.1016/S0022-3476(71)80465-1